Research & Development: Page 40
-
PharmaVoice Team/PharmaVoice
The Calendar
Coming Attractions The Global Site Solutions Summit, produced by the Society for Clinical Research Sites (SCRS), is committed to being “the site’s meeting." The conference provides a unique hub where sites, sponsors, CRO executives, and regulators come together and share best practices; build the...
By PharmaVoice Team • Oct. 1, 2016 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
The Future of Research All the innovation that is happening in research labs around the globe may come to naught if the sites, patients, and physician investigators needed to move the science forward are not a substantive part of the equation. In this month’s cover story “Why Sites Matter," the c...
By Taren Grom • Sept. 1, 2016 -
Explore the Trendline➔
Stock via Getty Images
TrendlineOncology
As investments in cancer R&D stay high, waves of innovative new treatments are on the horizon.
By PharmaVoice staff -
PharmaVoice Team/PharmaVoice
Upfront
Industry at Large MMRF, Takeda, and CURE Media Join Forces to Support Hiking Team A team of 20 multiple myeloma patients, caregivers, physicians, nurses, and supporters hiked along Peru’s arduous Inca Trail leading to the ruins of Machu Picchu to raise funds for research and to build awareness ar...
By PharmaVoice Team • Sept. 1, 2016 -
PharmaVoice Team/PharmaVoice
mHealth
Battery-less, Stretchable Patch Provides More Options for Health Monitoring Trending now: Innovative solutions lead to next generation mHealth tools. John Rogers, Ph.D., founder of MC10 and a materials scientist at the University of Illinois at Urbana-Champaign, has introduced a wearable electro...
By PharmaVoice Team • Sept. 1, 2016 -
PharmaVoice Team/PharmaVoice
Last Word
Following the Science Bill Hinshaw, Executive VP and Head of Novartis Oncology US, talks about the company’s efforts to create innovation in the cancer arena. PV: What is Novartis doing to encourage innovation? Hinshaw: Transforming cancer care is a core part of our mission. Novartis as a corpora...
By Bill Hinshaw • Sept. 1, 2016 -
PharmaVoice Team/PharmaVoice
Why Sites Matter
Clinical sites face several challenges, including predictability of trial business, payments, and technology issues, in addition to a highly fragmented clinical trial landscape. Many of the challenges that sites face reflect the changing landscape of clinical research. Sites are responsible for m...
By Denise Myshko • Sept. 1, 2016 -
PharmaVoice Team/PharmaVoice
Principal Investigator Turnover
The principal investigator (PI) landscape is in flux. According a 2015 survey from the Tufts Center for the Study of Drug Development, persistently high turnover rates among PIs create instability and present an additional challenge for sponsors and CROs. While the number of investigators globall...
By Denise Myshko • Sept. 1, 2016 -
PharmaVoice Team/PharmaVoice
Tools of the Trade
New Company Launches to Address Preclinical Research Trending now: Vium aims to bridge the technology gap in preclinical research to accelerate drug development. Vium has officially launched, offering Digital Vivarium and Vium Cloud, which bridge a technology gap in preclinical in vivo drug rese...
By PharmaVoice Team • Aug. 1, 2016 -
PharmaVoice Team/PharmaVoice
Who's On The List by Section
This article contains the list of 100 honorees. If you want to read the article featuring a particular person, please view the Section in which he/she is featured. Commanders & Chiefs Julie Adrian Chandler Chicco Agency, inVentiv Health Mary Anderson Ogilvy CommonHealth Medical Educatio...
By PharmaVoice Team • Aug. 1, 2016 -
PharmaVoice Team/PharmaVoice
Born Leaders A Global Perspective
This year, the homelands of the PharmaVOICE 100 account for almost 20 different countries or territories — from Russia to the West Indies, from Scotland to New Zealand, and from the United States to Australia and various points in between. Six of our honorees — Ken Keller, Stu Libby, Jennifer Mat...
By PharmaVoice Team • Aug. 1, 2016 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
Scurvy + Science In May 1747, the HMS Salisbury of Britain’s Royal Navy fleet was patrolling the English Channel at a time when scurvy is thought to have killed more British seamen than French and Spanish arms. According to the Association of Clinical Research Professionals (ACRP), aboard this sh...
By Taren Grom • June 1, 2016 -
PharmaVoice Team/PharmaVoice
UpFront
Industry at Large Sanofi Genzyme Donates Corporate Archives To Harvard Business School Sanofi Genzyme is donating materials to create an extensive archival collection, spanning the more than three decades since the company’s founding in 1981, to the Historical Collections of Harvard Business Scho...
By PharmaVoice Team • June 1, 2016 -
PharmaVoice Team/PharmaVoice
Innovator's Corner
A “Universal" Flu Vaccine in the Works Tim Alefantis, Ph.D., Sanofi Pasteur’s R&D lead on the second-generation vaccine program, and Sam Lee, Ph.D., project strategy for Sanofi Pasteur’s pandemic and new influenza vaccines, talk about the company’s work to develop a broadly effective influen...
By Tim Alefantis • June 1, 2016 -
PharmaVoice Team/PharmaVoice
2016 DIA Preview
This year’s annual meeting of the Drug Information Association is expected to draw more than 7,000 attendees for the largest global interdisciplinary gathering of life-sciences professionals. DIA 2016 is packed with more than 175 educational offerings over 22 tracks on today’s hottest topics, and...
By PharmaVoice Team • June 1, 2016 -
PharmaVoice Team/PharmaVoice
CNS Research Challenges
Neurological disorders consist of more than 600 conditions, impacting an estimated 50 million Americans every year. Although some are well known, many are rare disorders that affect a small number of patients who currently have access to few, if any, effective treatments. Research in the CNS area...
By Denise Myshko • June 1, 2016 -
PharmaVoice Team/PharmaVoice
China: An Emerging Pharmaceutical Super Power
Over the past 25 years, China has been on an extraordinary economic trajectory. Economic and political reforms that were implemented in the latter part of the last century have transformed the country. “The result is the emergence of a new economic and political super power with global GDP perfor...
By Kim Ribbink • June 1, 2016 -
PharmaVoice Team/PharmaVoice
SHOWCASE FEATURE: Clinical Trial Solutions: Serving the Clinical Trial Ecosystem
With drug development costs topping $2 billion, R&D spending at an all time high, and as the global market for clinical trials continues to grow and diversify, there is increasing pressure on the industry to bring drugs, biologics, and devices to market with increased speed and greater effici...
By Taren Grom • June 1, 2016 -
PharmaVoice Team/PharmaVoice
Inside the Central Laboratory Model For Clinical Trials Diagnostic Testing
Central laboratories — charged with providing harmonized clinical diagnostic testing and a consolidated database for clinical trial sponsors — continue to evolve against the backdrop of an increasingly complex clinical trial environment. Today the industry balances the demands of complicated labo...
By Mark Engelhart • June 1, 2016 -
PharmaVoice Team/PharmaVoice
Are You Ready for Risk-Based Monitoring? Conditions for RBM Readiness
Choosing your first risk-based monitoring (RBM) program is a big decision. As RBM continues to gain traction in many clinical programs across our industry, it is important to know how to evaluate when RBM is the best choice for your development program. Service providers have been confronted by v...
By Cheryle Evans • June 1, 2016 -
PharmaVoice Team/PharmaVoice
More Than Child's Play: Uncovering the Role of Video Games in Patient Education
Over the past few decades, advances in technology and creative talent from programmers, artists, and writers have spawned a new generation of video games and those who play them, contributing to a $22.4 billion market. Many people assume video games are for entertainment only, but that assumption...
By Allison R. Musante • June 1, 2016 -
PharmaVoice Team/PharmaVoice
How Bring Your Own Device and Other Innovations Are Improving Patient Engagement
Improving how patients participate in clinical trials is an essential challenge for the industry. The past few years have seen an encouraging shift of attention to the various ways we can improve patient engagement in research programs. In the past, patient engagement focused on how we recruit su...
By Adam Butler • June 1, 2016 -
PharmaVoice Team/PharmaVoice
Patient-Centricity Key to Rare Disease Trial Success
Patient-centricity has become a buzzword in the clinical development world. But for rare disease trials, “putting patients first" isn’t just an ideal, it’s an essential element to the success of such studies. The challenges of recruiting and retaining sufficient patient numbers to power a study t...
By Scott Gray • June 1, 2016 -
PharmaVoice Team/PharmaVoice
Shared Investigator Platform Making Life Easier For Clinical Investigators
Life sciences companies are under continual pressure to reduce clinical trial costs and the time it takes to bring a new therapy to market. Clinical trial challenges include subject retention, medical adherence, and managing the huge volume of administrative documents and tasks required of invest...
By Bhaskar Sambasivan • June 1, 2016 -
PharmaVoice Team/PharmaVoice
Clinical Performance Management
Today, global biopharma and medical device companies lament their inability to effectively harness the wealth of data they generate to help guide their thinking and inform decisions. The result is that organizations require valuable resources to spend enormous amounts of time preparing reports t...
By Larry Florin • June 1, 2016 -
PharmaVoice Team/PharmaVoice
Thoughtful Technology to Reduce Burden For Clinical Trial Sites and Patients
The concept of patient-centricity in research is about offering patients a better clinical trial experience. As such, there are a variety of ways to enhance the engagement of the patient. These include empowering other key stakeholders — sponsors, CROs, and sites — with better tools to improve th...
By Kevin T. Williams • June 1, 2016
Previous
